New drug from Gensight Biologics hits pipeline
Bernard Gilly, PhD
Advertisement
CEO, Gensight Biologics
Articles by Bernard Gilly, PhD
Advertisement
Latest Updated Articles
Pipeline: New therapies to come for debilitating eye diseasesNovember 12th 2020
Advertisement
Advertisement
Trending on Optometry Times - Clinical News & Expert Optometrist Insights
1
BIM-IOL System holds 37% IOP reduction at 4 years in first-in-human trial
2
Takeaways from this week in optometry: October 16-23
3
Brepocitinib for noninfectious uveitis meets all phase 3 trial end points
4
More than monitoring: Using AMD visits to promote healthy vision aging
5